News
Good morning. Today, we read about the implications of mRNA funding cuts on national security, see layoffs at gene-editing ...
In May, it announced it would acquire SiteOne Therapeutics, a drugmaker with a promising investigational medicine for pain.
Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...
A backlash against a White House video promoting deportation and Casalonga opening a new office in Düsseldorf were also among the top talking points ...
Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year ...
Eli's Cheesecake is giving away free slices at three Chicago locations on National Cheesecake Day. CHICAGO (WLS) -- Eli's Cheesecake is slicing into its 45th anniversary with sweet generosity.
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
LTZ Therapeutics (“LTZ”), an immunotherapy-focused biotechnology company, today announced a strategic research collaboration with Eli Lilly and Company (“Lilly”) to develop novel myeloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results